| Literature DB >> 32540279 |
David de la Rosa Carrillo1, José Luís López-Campos2, Bernardino Alcázar Navarrete3, Myriam Calle Rubio4, Rafael Cantón Moreno5, Juan Luis García-Rivero6, Luís Máiz Carro7, Casilda Olveira Fuster8, Miguel Ángel Martínez-García9.
Abstract
Although the chronic presence of microorganisms in the airways of patients with stable chronic obstructive pulmonary disease (COPD) confers a poor outcome, no recommendations have been established in disease management guidelines on how to diagnose and treat these cases. In order to guide professionals, the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) has prepared a document which aims to answer questions on the clinical management of COPD patients in whom microorganisms are occasionally or habitually isolated. Since the available scientific evidence is too heterogeneous to use in the creation of a clinical practice guideline, we have drawn up a document based on existing scientific literature and clinical experience, addressing the definition of different clinical situations and their diagnosis and management. The text was drawn up by consensus and approved by a large group of respiratory medicine experts with extensive clinical and scientific experience in the field, and has been endorsed by the SEPAR Scientific Committee.Entities:
Keywords: Bronchiectasis; Bronquiectasias; Chronic bronchial infection; Chronic obstructive pulmonary disease; Corticosteroides inhalados; Enfermedad pulmonar obstructiva crónica; Infección bronquial crónica; Inhaled antibiotic treatment; Inhaled corticosteroids; Macrolides; Macrólidos; Tratamiento antibiótico inhalado
Mesh:
Year: 2020 PMID: 32540279 DOI: 10.1016/j.arbres.2020.04.023
Source DB: PubMed Journal: Arch Bronconeumol (Engl Ed) ISSN: 0300-2896 Impact factor: 4.872